Explain method to educate patient on prevention of cirrhosis

The rate of species extinction on earth
April 13, 2020
Solution-What is an example of eating non-sustainably
April 13, 2020

Explain method to educate patient on prevention of cirrhosis

Nursing Assignment: Cirrhosis of the Liver

Cirrhosis of the liver is a common disorder that can severely impact patients’ lives. It is important to consider the many potential causes of cirrhosis and monitor patients that are likely candidates for the disorder. This allows the opportunity for prevention or, in some cases, early intervention. Patient education on prevention is critical because cirrhosis can lead to other serious disorders, including liver cancer. In this Discussion, you further explore causes of cirrhosis and the impact of the disorder on patients.

To prepare:

· Review this week’s media presentations on the gastrointestinal system, as well as the Starr article in the Learning Resources.
· Consider the pathophysiology of cirrhosis of the liver.
· Reflect on potential causes of cirrhosis and select one to be the focus of your Discussion. Consider additional health issues resulting from your selected cause.
· Think about drugs that might be used to slow down the progression of cirrhosis, including treatments for these health issues.
· Consider patient education methods for the prevention of cirrhosis.

Questions to be addressed in my paper:

1. An explanation of the pathophysiology of cirrhosis of the liver.
2. Include an explanation of two additional health issues resulting from one cause of cirrhosis.
3. Then, describe drugs that might be used to slow down the progression of cirrhosis, including treatments for these health issues.
4. Explain methods to educate patients on the prevention of cirrhosis.
5. Summary with Conclusion

REMINDERS:

1) 2-3 pages (addressing the 4 questions above excluding the title page and reference page).
2) Kindly follow APA format for the citation and references! References should be between the period of 2011 and 2016. Please utilize the references at least three below as much as possible and the rest from yours.
3) Make headings for each question.

References:

Readings

· Huether, S. E., & McCance, K. L. (2012). Understanding pathophysiology (Laureate custom ed.). St. Louis, MO: Mosby.

o Chapter 33, “Structure and Function of the Digestive System”

This chapter provides information relating to the structure and function of the digestive system. It covers the gastrointestinal tract and accessory organs of digestion.

o Chapter 34, “Alterations of Digestive Function”

This chapter presents information relating to disorders of the gastrointestinal tract and accessory organs of digestion. It also covers the pathogenesis, clinical manifestations, evaluation, and treatment of gastroesophageal reflux disease, gastritis, peptic ulcer disease, inflammatory bowel disease, and irritable bowel syndrome.

o Chapter 35, “Alterations of Digestive Function in Children”

This chapter presents information relating to disorders of the gastrointestinal tract and liver that affect children. It focuses on congenital impairment, inflammatory disorders, and metabolic disorders, as well as the impairment of digestion, absorption, and nutrition.

Poole Arcangelo, V., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.

o Chapter 28, “Nausea and Vomiting”

This chapter focuses on the etiology of nausea and vomiting, as well as body systems that impact or trigger nausea and vomiting. It also covers various drugs used to treat nausea and vomiting, including the process of selecting, administering, and managing drug therapy for patients.

o Chapter 29, “Gastroesophageal Reflux Disease and Peptic Ulcer Disease”

This chapter begins with an overview of risk factors, symptoms, and clinical stages of gastroesophageal reflux disease (GERD). It then examines drugs used to treat GERD and peptic ulcer disease (PUD), including proper dosages, possible adverse reactions, contraindications, and special considerations.

o Chapter 30, “Constipation, Diarrhea, and Irritable Bowel Syndrome”

This chapter begins by exploring disorders associated with constipation and diarrhea, as well as drugs used in treatment. It also covers the pathophysiology of irritable bowel syndrome and related drug therapies.

o Chapter 31, “Inflammatory Bowel Disease”

This chapter examines the causes, pathophysiology, and diagnostic criteria of inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis. It also identifies drugs used to treat IBD, including proper dosage, adverse reactions, and special considerations.

Starr, S. P., & Raines, D. (2011). Cirrhosis: Diagnosis, management, and prevention. American Family Physician, 84(12), 1353-1359.

Retrieved from the Walden Library databases.

This article examines the clinical presentation, pathophysiology, diagnosis, management, and prevention of cirrhosis. It also provides methods for managing complications of cirrhosis.

Drugs.com. (2012). Retrieved from www.drugs.com

This website presents a comprehensive review of prescription and over-the-counter drugs, including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.

Media

· Laureate Education, Inc. (Executive Producer). (2012e). The gastrointestinal system. Baltimore, MD: Author.

This media presentation outlines the pathophysiology of the gastrointestinal system and associated alterations.

· Laureate Education, Inc. (Executive Producer). (2012j). Pharmacology for the gastrointestinal system. Baltimore, MD: Author.

This media presentation outlines drug treatment options for disorders of the gastrointestinal system.

Optional Resources

· American Liver Foundation. (2012). Retrieved from http://www.liverfoundation.org/
· Centers for Disease Control and Prevention. (n.d.). Retrieved August 10, 2012, fromhttp://www.cdc.gov
· Haymarket Media, Inc. (2012). Monthly prescribing reference [Online database]. Retrieved fromhttp://www.empr.com/
· Institute for Safe Medication Practices. (2012). Retrieved from http://www.ismp.org/
· Medscape. (2012). Retrieved from http://www.medscape.com/
· National Digestive Diseases Information Clearinghouse. (2012). Retrieved fromhttp://digestive.niddk.nih.gov/index.aspx